Login

Dr. Sundar Kamath, Senior VP & CTO of Sanmina Corp, San Jose, CA. 00:10:00

Share On Facebook Share On Twitter

Jure Sola is Chairman and Chief Executive Officer of Sanmina Corp

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Diversifying Wealth: Srikanth Narayan on Managing Concentrated Stock with Exchange Funds
00:10:00
Karla Briones Discusses the Immigrants Developing Entrepreneurs Academy (IDEA) and Its Benefits
00:10:00
CompoSecure CEO Jon Wilk on Global Expansion and Fintech Growth | Jon Wilk - CEO of CompoSecure
00:10:00
DWS Market Outlook with Björn Jesch - Insights on Positive Returns Amidst Economic Challenges
00:10:00
Investing In What’s Important is a series featuring EP Wealth Advisors' team, where Derek Holman, CFP®, AIF, discusses the benefits of the fee-only approach and its impact on clients, especially small business owners and executives.
00:10:00
CEO Rosario Pingaro Discusses the Future-Proof Vision of Convergenze: A Leading Multiutility | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Reasons for Being Christian: Insights from Professor Thomas Ward|Thomas Ward,Professor,Baylor University
00:10:00
Building the Future: Larry Fink of BlackRock and Adebayo Ogunlesi of GIP Discuss $12.5 Billion Deal and the Infrastructure Revolution
00:10:00
Insights from BKW's CEO on Profit, Strategy, and Energy Transition |Robert Itschner, CEO, BKW AG.
00:10:00
Reimagining the Workplace: Brent Saunders on the Permanent Shift to Remote Work |Brent Saunders , CEO, Bausch + Lomb Corp.
00:00:00
Lloyd Diamond, CEO, Pixium Vision S
00:00:00
Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial - Michael Hunt, Chief Financial Officer, ReNeuron Group

© 2026 Nehu